Literature DB >> 19785952

[Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].

Xin Xiang1, Wen-bo Zhao, Xin Wang.   

Abstract

OBJECTIVE: To study the expression and significance of endothelial cell specific molecule-1 (ESM-1) in hepatocellular carcinoma (HCC) tissue and serum from HCC patients.
METHODS: The ESM-1 expression was evaluated by immunohistochemistry staining and quantitative real-time PCR in 30 tumor tissues from HCC patients, 15 surrounding non-cancerous hepatic parenchyma, and 15 normal controls. Serum levels of ESM-1 were also measured in the HCC patients and healthy controls by Enzyme-linked immunosorbent assay (ELISA).
RESULTS: ESM-1 was expressed in endothelium of 24 HCC tissues and 6 pericarcinomatous tissues, however, it was not expressed in normal liver tissues. The mRNA level of ESM-1 was 0.064 +/- 0.018, 0.383 +/- 0.103, 0.528 +/- 0.148 in the corresponding tissues, respectively. The mRNA level of ESM-1 in tissues was correlated with the TNM phase of HCC patients, tumor vascular invasion as well as metastasis. The serum ESM-1 was (12.643 +/- 2.280) ng/ml and (4.660 +/- 1.172) ng/ml in hepatic cell carcinoma and normal controls, respectively.
CONCLUSION: The expression of ESM-1 is significantly up-regulated in HCC, suggesting that ESM-1 may play an important role in the pathoigenesis of HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19785952

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  2 in total

1.  Endocan: A new marker for cancer and a target for cancer therapy.

Authors:  Jinghui Yang; Qiwei Yang; Shan Yu; Xuewen Zhang
Journal:  Biomed Rep       Date:  2015-02-26

2.  Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.

Authors:  Maryse Delehedde; Lucie Devenyns; Claude-Alain Maurage; Romain R Vivès
Journal:  Int J Cell Biol       Date:  2013-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.